Silk Road Med
Bookmark
ShareCopied to clipboardSilk Road Med is a company. It is a public company in Sunnyvale, the United States. It was founded in 2007 and its current CEO is Erica J. Rogers. It is part of the Health Care sector, specifically in the Health Care Equipment & Supplies industry.
Key facts
- city: Sunnyvale
- state: CA
- country: United States
- employees: 352 people
- revenues: 114.2M $
- company type: public
- sector: Health Care
- industry: Health Care Equipment & Supplies
- foundation year: 2007
- CEO: Erica J. Rogers
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Silk Road Med:
Dataset of stocks from Silk Road Med:
Silk Road Med is one of the companies in the United States, companies in Health Care Equipment & Supplies, companies in Health Care, companies in Sunnyvale and 3,456,808 companies in our database.
Talking Points
- Silk Road Medical | Official Engineers Of The TCAR Procedure
- Silk Road Medical Developed TCAR - The Transcarotid Artery Revascularization Procedure. Achieving brighter patient outcomes through brighter clinical thinking.
- Silk Road Medical is focused on reducing the risk of stroke and its devastating impact, and has pioneered a new approach to treat carotid artery disease.
- Brighter patient outcomes through brighter clinical thinking | Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery ...
- Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.